Drug's Life 2015 - Webinar on Extending Your Drug's Life

Overview:
This course will describe how a pharmaceutical company can prolong the life of a drug product. The high cost of time, money, and man-hours to develop a new pharmaceutical drug requires that the company hang onto the drug especially during the patent period.
This webinar will describe how a pharmaceutical company can prolong the life of a drug product. Examples will include new formulations, indications, and additional patient populations. Healthy pharmaceutical companies take pride in adding years to a drug's patent life. People who are responsible for this result are often promoted because of the positive effect on the company's health.
Why should you Attend:
Healthy pharmaceutical companies take pride in adding years to a pharmaceutical product's life. People who are responsible for this result are often promoted because of the positive effect on the company's health. As employees stay with the company and get older, there is often a fear that the company will not continue to keep a person employed especially as he/she gets closer to pension age. They need to get associated with a drug's name and longevity.
Areas Covered in the Session:
Pharmaceutical companies have numerous areas that are associated with most drugs. In the business side marketing looks to prepare advertising to prescribers and potential patients. Pharmaceutical formulation areas develop a new formulation and their colleagues make the new product for millions of patients. Scientists working with animals obtain basic safety information for a particular population that does not have data in the past. Clinical scientists develop safety, pharmacokinetic, and efficacy data to form the center of the Investigational New Drug (IND) application for getting the drug approved by the FDA.
This webinar will describe how a pharmaceutical company can prolong the life of a drug product using:
New formulations
Indications
Additional patient populations
Who Will Benefit:
Healthy pharmaceutical companies take pride in adding years to a pharmaceutical product's life. People who are responsible for this result are often promoted because of the positive effect on the company's health. As employees stay with the company and get older, there is often a fear that the company will not continue to keep a person employed especially as he/she gets closer to pension age. They need to get associated with a drug's name and longevity.
Speaker Profile:
Bob Kunka Ph.D. is an accomplished and respected scientist who contributed to the development of 28 approved pharmaceutical products in eight therapeutic areas. His expertise on international product development teams produced submissions with successful clinical strategies, sound matrix management of individual study teams, and effective interactions with regulatory agencies leading to successful IND, aNDA, and NDA approvals.
Contact Detail:
NetZealous - Compliance4All,
161 Mission Falls Lane, Suite 216,
Fremont, CA 94539, USA.
Phone: +1-800-447-9407
Email: support-AT-compliance4All.com
http://www.compliance4all.com/
Event Link : http://bit.ly/1gLXQjC